What is Claims Eval?
Claims Eval operates as a URAC-accredited Independent Review Organization, providing a specialized bridge between complex medical data and insurance adjudication. The company maintains a national panel of board-certified, active-practice physicians who deliver objective, defendable, and evidence-based assessments regarding causality and appropriateness of care. By focusing on the intersection of clinical expertise and administrative efficiency, Claims Eval addresses the critical need for transparency in the Auto, Liability, and Workers' Compensation sectors. Their market position is defined by a rigorous adherence to standards of care, ensuring that every consultation is grounded in current medical developments and regulatory compliance.
How much funding has Claims Eval raised?
Claims Eval has raised a total of $616K across 2 funding rounds:
Debt
$350K
Debt
$266K
Debt (2020): $350K with participation from PPP
Debt (2021): $266K led by PPP
Key Investors in Claims Eval
PPP
Public-Private Partnership
What's next for Claims Eval?
With the recent infusion of capital, Claims Eval is positioned to accelerate its strategic initiatives, likely focusing on the expansion of its physician network and the integration of advanced diagnostic review tools. The company's roadmap involves deepening its penetration into the Group Health market while maintaining the high-fidelity peer-to-peer consultation services that define its brand. As the demand for objective medical necessity reviews continues to rise due to increasing regulatory scrutiny and the complexity of disability claims, Claims Eval is well-equipped to scale its operations. Future growth will likely center on optimizing the speed and accuracy of its review cycles, ensuring that stakeholders receive conclusive, data-backed insights that mitigate risk and improve outcomes across the insurance ecosystem.
See full Claims Eval company page
